Watch Ticker

Compass Therapeutics, Inc. Common Stock

Go to Compass Therapeutics, Inc. Common Stock Website

$2.91

0.00 (0.00%)

Live

Previous Close

$2.91

Day Range

$0 - $0

Previous Day Range

$2.7509 - $2.94

Market Cap

$405.2 million USD

Day Vol.

Previous Day Vol.

802966

Currency

USD

Primary Exchange

Nasdaq

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Marketbeat.Com - Top 3 High-Momentum Companies Analysts Are Still Bullish On

Three companies with recent stock rallies that analysts remain bullish on are Compass Therapeutics, Amprius Technologies, and Allot Communications. Analysts see significant upside potential in these momentum stocks despite their recent gains.

Related tickers: CMPX, AMPX, AMPX.WS, ALLT.

Read Full Article

N/A - Compass Therapeutics to Participate in Upcoming Investor Events

Compass Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in two investor conferences in September 2024, where it will present updates on its oncology-focused pipeline of antibody-based therapeutics.

Related tickers: CMPX.

Read Full Article

Trending Tickers

Please sign in to view